Pure Global

Aspergillus fumigatus IgG ELISA - India CDSCO Medical Device Registration

Aspergillus fumigatus IgG ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000101_e369c1c7bb012de130fe964eca51fa6f_19a35bd73e1d7b61feb9a23b39b10bf5. This device is marketed under the brand name NovaLisa. The license holder is Dia Sure Immunodiagnostic LLP, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Aspergillus fumigatus IgG ELISA
UID: IMP/IVD/2021/000101_e369c1c7bb012de130fe964eca51fa6f_19a35bd73e1d7b61feb9a23b39b10bf5

Brand Name

NovaLisa

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Aspergillus fumigatus IgG ELISA is intended for the qualitative determination of IgG class antibodies against Aspergillus fumigatus in human serum or plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing